hydrazine has been researched along with Leishmaniasis, Visceral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilera, E; Álvarez, G; Aparicio, G; Cabrera, N; Cerecetto, H; Coronel, C; González, M; Perdomo, C; Pérez-Montfort, R; Rojas de Arias, A; Rolón, M; Varela, J; Vega, C; Zolessi, FR | 1 |
| Aldana, I; Barea, C; Deharo, E; Galiano, S; Pabón, A; Quiliano, M; Ramirez-Calderon, G | 1 |
2 other study(ies) available for hydrazine and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Multi-Anti-Parasitic Activity of Arylidene Ketones and Thiazolidene Hydrazines against Trypanosoma cruzi and Leishmania spp.
Topics: Animals; Cell Line; Chagas Disease; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Hydrazines; Ketones; Leishmania braziliensis; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Mice; Thiazolidines; Trypanocidal Agents; Trypanosoma cruzi; Zebrafish | 2017 |
New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity.
Topics: Antiprotozoal Agents; Humans; Hydrazines; Leishmania infantum; Leishmaniasis, Visceral; Malaria, Falciparum; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship | 2017 |